Literature DB >> 23333830

Combined antiallodynic effect of Neurotropin® and pregabalin in rats with L5-spinal nerve ligation.

Ryohei Okazaki1, Hiroyoshi Namba, Hiroyuki Yoshida, Hisashi Okai, Kazuki Taguchi, Minoru Kawamura.   

Abstract

AIMS: In this study, we investigated the combined effect of Neurotropin® and pregabalin for L5-spinal nerve ligation (L5-SNL) model in rats and thiopental-induced sleep in mice. MAIN
METHODS: The left fifth lumbar nerve of rats was tightly ligated with silk sutures under pentobarbital anesthesia. The hindpaw withdrawal threshold was measured by application of von Frey filaments. Thiopental sodium was intravenously administered in mice and sleeping time was measured. In L5-SNL rats, an isobolographic analysis was performed to clarify the combined antiallodynic effect of Neurotropin and pregabalin 14 days after ligation in rats. In isobolographic analysis and thiopental-induced sleep test, Neurotropin and pregabalin were orally administered to coincide with the timing of the peak effect of each drug. KEY
FINDINGS: Neurotropin (50-200 NU/kg) and pregabalin (2.5-10mg/kg) showed a dose-dependent antiallodynic action in L5-SNL rats. The antiallodynic effect of pregabalin was reversed by intrathecal injection of yohimbine or ondansetron. Isobolographic analysis suggested that the combined antiallodynic effect of Neurotropin and pregabalin in L5-SNL rats may have been more than a mere additive effect. Neurotropin (50-400 NU/kg) had no effect on thiopental-induced sleeping time whereas pregabalin (30-100mg/kg) significantly prolonged it. When the dose of pregabalin was 30 mg/kg, Neurotropin (50-400 NU/kg) did not further exacerbate the prolongation effect of pregabalin on thiopental-induced sleep. SIGNIFICANCE: It was suggested that when Neurotropin was administered in combination with pregabalin, it might provide more effective pain relief than that obtained with each agent alone in neuropathic pain without aggravating adverse effects of pregabalin.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23333830     DOI: 10.1016/j.lfs.2012.12.009

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Anti-allodynic Efficacy of NMDA Antagonist Peptide and Noradrenaline Alone and in Combination in Rodent Neuropathic Pain Model.

Authors:  Farinaz Nasirinezhad; Marjan Hosseini; Sajad Salari
Journal:  Korean J Pain       Date:  2015-04-01

2.  Success with neurotropin in treating pediatric lower extremity pain induced by spinal cord injury after epidural anesthesia.

Authors:  Mengye Zhu; Fuqing Zhou; Lingchao Li; Qin Yin; Mizhen Qiu; Yong Zhang
Journal:  J Pain Res       Date:  2017-06-06       Impact factor: 3.133

3.  Neurotropin® Accelerates the Differentiation of Schwann Cells and Remyelination in a Rat Lysophosphatidylcholine-Induced Demyelination Model.

Authors:  Hozo Matsuoka; Hiroyuki Tanaka; Junichi Sayanagi; Toru Iwahashi; Koji Suzuki; Shunsuke Nishimoto; Kiyoshi Okada; Tsuyoshi Murase; Hideki Yoshikawa
Journal:  Int J Mol Sci       Date:  2018-02-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.